Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease.

[1]  C. Jakubzick,et al.  Biology of lung macrophages in health and disease. , 2022, Immunity.

[2]  Jinsheng Hong,et al.  Extracellular matrix of early pulmonary fibrosis modifies the polarization of alveolar macrophage. , 2022, International immunopharmacology.

[3]  Xiao Han,et al.  Eucalyptol prevents bleomycin-induced pulmonary fibrosis and M2 macrophage polarization. , 2022, European journal of pharmacology.

[4]  Y. Fujita.  Extracellular vesicles in idiopathic pulmonary fibrosis: pathogenesis and therapeutics , 2022, Inflammation and Regeneration.

[5]  Wen Zhang,et al.  Cannabinoid Analogue WIN 55212–2 Protects Paraquat-Induced Lung Injury and Enhances Macrophage M2 Polarization , 2022, Inflammation.

[6]  E. Leung,et al.  Integrated Analysis of Single-Cell and Bulk RNA Sequencing Reveals Pro-Fibrotic PLA2G7high Macrophages in Pulmonary Fibrosis. , 2022, Pharmacological research.

[7]  F. Martinez,et al.  Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , 2022, American journal of respiratory and critical care medicine.

[8]  A. Ashare,et al.  ScRNA-seq expression of IFI27 and APOC2 identifies four alveolar macrophage superclusters in healthy BALF , 2022, Life Science Alliance.

[9]  W. Xiong,et al.  Macrophage‐targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis , 2021, Bioengineering & translational medicine.

[10]  P. Zhao,et al.  Effective-compound combination inhibits the M2-like polarization of macrophages and attenuates the development of pulmonary fibrosis by increasing autophagy through mTOR signaling. , 2021, International immunopharmacology.

[11]  Honggang Zhou,et al.  Clevudine attenuates bleomycin-induced early pulmonary fibrosis via regulating M2 macrophage polarization. , 2021, International immunopharmacology.

[12]  A. Niimi,et al.  Suppression of epithelial abnormalities by nintedanib in induced-rheumatoid arthritis-associated interstitial lung disease mouse model , 2021, ERJ Open Research.

[13]  Siwei Jin,et al.  Dehydrocostus Lactone Attenuates Methicillin-Resistant Staphylococcus aureus-Induced Inflammation and Acute Lung Injury via Modulating Macrophage Polarization , 2021, International journal of molecular sciences.

[14]  Chuanyuan Wei,et al.  M2-polarized macrophages mediate wound healing by regulating connective tissue growth factor via AKT, ERK1/2, and STAT3 signaling pathways , 2021, Molecular Biology Reports.

[15]  K. Ask,et al.  Monocyte and macrophage derived myofibroblasts: Is it fate? A review of the current evidence , 2021, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[16]  B. Leavitt,et al.  The current landscape of nucleic acid therapeutics , 2021, Nature Nanotechnology.

[17]  K. Ask,et al.  Cell-Specific Drug Targeting in the Lung. , 2021, Biochemical pharmacology.

[18]  Jianzhu Chen,et al.  High-throughput phenotypic screen and transcriptional analysis identify new compounds and targets for macrophage reprogramming , 2021, Nature Communications.

[19]  Huaiyong Chen,et al.  Macrophages in Lung Injury, Repair, and Fibrosis , 2021, Cells.

[20]  W. Xiong,et al.  Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis , 2021, Theranostics.

[21]  Yamei Chen,et al.  Pirfenidone modulates macrophage polarization and ameliorates radiation‐induced lung fibrosis by inhibiting the TGF‐β1/Smad3 pathway , 2020, Journal of cellular and molecular medicine.

[22]  S. Zhuang,et al.  Inhibition of EZH2 prevents acute respiratory distress syndrome (ARDS)-associated pulmonary fibrosis by regulating the macrophage polarization phenotype , 2020, Respiratory Research.

[23]  J. Mege,et al.  New Tools for Studying Macrophage Polarization: Application to Bacterial Infections , 2020, Macrophages.

[24]  P. Taylor,et al.  Macrophage reprogramming for therapy , 2020, Immunology.

[25]  N. Zhang,et al.  Schisandra Inhibit Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rats via Suppressing M2 Macrophage Polarization , 2020, BioMed research international.

[26]  X. Gui,et al.  Association of serum macrophage-mannose receptor CD206 with mortality in idiopathic pulmonary fibrosis. , 2020, International immunopharmacology.

[27]  P. Low,et al.  Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis , 2020, EMBO molecular medicine.

[28]  O. Fardel,et al.  Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: perspectives for scleroderma-associated interstitial lung disease. , 2020, Biochemical pharmacology.

[29]  V. Cesari,et al.  Amniotic MSCs reduce pulmonary fibrosis by hampering lung B‐cell recruitment, retention, and maturation , 2020, Stem cells translational medicine.

[30]  M. Kolb,et al.  Current models of pulmonary fibrosis for future drug discovery efforts , 2020, Expert opinion on drug discovery.

[31]  P. Sly,et al.  Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis. , 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[32]  A. Mansour,et al.  Ameliorative effect of 2-methoxyestradiol on radiation-induced lung injury. , 2020, Life sciences.

[33]  Lei Xing,et al.  Nanoengineered immunosuppressive therapeutics modulating M1/M2 macrophages into the balanced status for enhanced idiopathic pulmonary fibrosis therapy. , 2020, Nanoscale.

[34]  Tiantian Sun,et al.  Reference gene selection and validation for mRNA expression analysis by RT-qPCR in murine M1- and M2-polarized macrophage , 2020, Molecular Biology Reports.

[35]  Dawei Li,et al.  High-Throughput Transcriptome Profiling in Drug and Biomarker Discovery , 2020, Frontiers in Genetics.

[36]  Xiufen Zheng,et al.  Microcystin-LR ameliorates pulmonary fibrosis via modulating CD206+ M2-like macrophage polarization , 2020, Cell Death & Disease.

[37]  D. Bennett,et al.  Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis , 2020, Respiratory Physiology & Neurobiology.

[38]  H. Perlman,et al.  A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages , 2019, European Respiratory Journal.

[39]  M. Selman,et al.  The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis. , 2019, Cellular signalling.

[40]  A. Fernandez-Gonzalez,et al.  Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes. , 2019, JCI insight.

[41]  R. Weissleder,et al.  Screening for new macrophage therapeutics , 2019, Theranostics.

[42]  S. Walsh,et al.  Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. , 2019, The New England journal of medicine.

[43]  M. Morosini,et al.  Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[44]  K. Muthusamy,et al.  Tannic acid prevents macrophage-induced pro-fibrotic response in lung epithelial cells via suppressing TLR4-mediated macrophage polarization , 2019, Inflammation Research.

[45]  P. Benos,et al.  Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis , 2019, European Respiratory Journal.

[46]  Dalia Haydar,et al.  Azithromycin Polarizes Macrophages to an M2 Phenotype via Inhibition of the STAT1 and NF-κB Signaling Pathways , 2019, The Journal of Immunology.

[47]  L. Vernhet,et al.  Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib. , 2019, International immunopharmacology.

[48]  A. Shilatifard,et al.  Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis , 2019, American journal of respiratory and critical care medicine.

[49]  Tianmin Xu,et al.  Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview , 2019, Front. Oncol..

[50]  Mian Zhang,et al.  Stemona alkaloids suppress the positive feedback loop between M2 polarization and fibroblast differentiation by inhibiting JAK2/STAT3 pathway in fibroblasts and CXCR4/PI3K/AKT1 pathway in macrophages. , 2019, International immunopharmacology.

[51]  I. Adcock,et al.  Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper , 2019, Allergy.

[52]  C. Théry,et al.  Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication , 2019, Nature Cell Biology.

[53]  M. Kondo,et al.  Preparation of Induced Pluripotent Stem Cells Using Human Peripheral Blood Monocytes , 2018, Cellular reprogramming.

[54]  R. Weissleder,et al.  Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages , 2018, Theranostics.

[55]  J. T. Afshari,et al.  Macrophage plasticity, polarization, and function in health and disease , 2018, Journal of cellular physiology.

[56]  Hongda Lu,et al.  Blockade of Aquaporin 4 Inhibits Irradiation-Induced Pulmonary Inflammation and Modulates Macrophage Polarization in Mice , 2018, Inflammation.

[57]  G. Raghu,et al.  Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial , 2018, JAMA.

[58]  R. Harding,et al.  The therapeutic effect of mesenchymal stem cells on pulmonary myeloid cells following neonatal hyperoxic lung injury in mice , 2018, Respiratory Research.

[59]  C. Doglioni,et al.  Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells , 2018, Nature Medicine.

[60]  D. Lederer,et al.  Idiopathic Pulmonary Fibrosis. , 2018, The New England journal of medicine.

[61]  J. López-Campos,et al.  The Expression of AQP1 IS Modified in Lung of Patients With Idiopathic Pulmonary Fibrosis: Addressing a Possible New Target , 2018, Front. Mol. Biosci..

[62]  S. Kubo,et al.  Pirfenidone suppresses polarization to M2 phenotype macrophages and the fibrogenic activity of rat lung fibroblasts , 2018, Journal of clinical biochemistry and nutrition.

[63]  Peter Chen,et al.  Single-Cell Deconvolution of Fibroblast Heterogeneity in Mouse Pulmonary Fibrosis , 2018, Cell reports.

[64]  W. Janssen,et al.  Deletion of c‐FLIP from CD11bhi Macrophages Prevents Development of Bleomycin‐induced Lung Fibrosis , 2018, American journal of respiratory cell and molecular biology.

[65]  Vinícius Andrade-Oliveira,et al.  Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis , 2018, Inflammopharmacology.

[66]  Yunxin Fu,et al.  Paralemmin-3 contributes to lipopolysaccharide-induced inflammatory response and is involved in lipopolysaccharide-Toll-like receptor-4 signaling in alveolar macrophages. , 2017, International journal of molecular medicine.

[67]  S. Teichmann,et al.  A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications , 2017, Genome Medicine.

[68]  C. Maier,et al.  Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis , 2017, Annals of the rheumatic diseases.

[69]  A. Shilatifard,et al.  Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span , 2017, The Journal of experimental medicine.

[70]  J. Debus,et al.  Effects of CTGF Blockade on Attenuation and Reversal of Radiation-Induced Pulmonary Fibrosis , 2017, Journal of the National Cancer Institute.

[71]  F. Ginhoux,et al.  Induced‐Pluripotent‐Stem‐Cell‐Derived Primitive Macrophages Provide a Platform for Modeling Tissue‐Resident Macrophage Differentiation and Function , 2017, Immunity.

[72]  Qian Zhang,et al.  M2A and M2C Macrophage Subsets Ameliorate Inflammation and Fibroproliferation in Acute Lung Injury Through Interleukin 10 Pathway , 2017, Shock.

[73]  Clarissa M Koch,et al.  Lung Interstitial Macrophages: Establishing Identity and Uncovering Heterogeneity. , 2017, American journal of respiratory cell and molecular biology.

[74]  P. Rocco,et al.  Bosutinib Therapy Ameliorates Lung Inflammation and Fibrosis in Experimental Silicosis , 2017, Front. Physiol..

[75]  S. Kameoka,et al.  Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease. , 2016, JCI insight.

[76]  S. Gharib,et al.  Lung Pericytes and Resident Fibroblasts: Busy Multitaskers. , 2016, The American journal of pathology.

[77]  Gordana Vunjak-Novakovic,et al.  Differential gene expression in human, murine, and cell line-derived macrophages upon polarization. , 2016, Experimental cell research.

[78]  Yutian Li,et al.  MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response , 2016, Shock.

[79]  C. Shimbori,et al.  GRP78 and CHOP modulate macrophage apoptosis and the development of bleomycin‐induced pulmonary fibrosis , 2016, The Journal of pathology.

[80]  Mian Zhang,et al.  Neotuberostemonine attenuates bleomycin-induced pulmonary fibrosis by suppressing the recruitment and activation of macrophages. , 2016, International immunopharmacology.

[81]  N. Burke,et al.  Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada , 2016, European Respiratory Journal.

[82]  Zhuoli Zhang,et al.  Inflammatory monocyte/macrophage modulation by liposome-entrapped spironolactone ameliorates acute lung injury in mice. , 2016, Nanomedicine.

[83]  R. Kolde,et al.  Flow Cytometric Analysis of Mononuclear Phagocytes in Nondiseased Human Lung and Lung-Draining Lymph Nodes. , 2016, American journal of respiratory and critical care medicine.

[84]  C. Takiya,et al.  Dasatinib Reduces Lung Inflammation and Fibrosis in Acute Experimental Silicosis , 2016, PloS one.

[85]  M. Mierzejewski,et al.  Macrophage polarization in interstitial lung diseases , 2014, Central-European journal of immunology.

[86]  A. Bharat,et al.  Flow Cytometry Reveals Similarities Between Lung Macrophages in Humans and Mice. , 2016, American journal of respiratory cell and molecular biology.

[87]  M. Kraft,et al.  Flow Cytometric Analysis of Myeloid Cells in Human Blood, Bronchoalveolar Lavage, and Lung Tissues. , 2016, American Journal of Respiratory Cell and Molecular Biology.

[88]  R. Medzhitov,et al.  Tissue biology perspective on macrophages , 2015, Nature Immunology.

[89]  C. Owen,et al.  Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis. , 2015, American journal of respiratory cell and molecular biology.

[90]  R. Fischer,et al.  Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies , 2015, mAbs.

[91]  C. Lo,et al.  Amnion cell-mediated immune modulation following bleomycin challenge: controlling the regulatory T cell response , 2015, Stem Cell Research & Therapy.

[92]  Weifang Shan,et al.  Chemically Synthesized Molecules with the Targeting and Effector Functions of Antibodies , 2014, Journal of the American Chemical Society.

[93]  B. Staels,et al.  Macrophage phenotypes in atherosclerosis , 2014, Immunological reviews.

[94]  J. Mes,et al.  THP-1 cell line: an in vitro cell model for immune modulation approach. , 2014, International immunopharmacology.

[95]  R. Gomer,et al.  Persistent Lung Inflammation and Fibrosis in Serum Amyloid P Component (Apcs-/-) Knockout Mice , 2014, PloS one.

[96]  M. Kuroda,et al.  In Vivo Characterization of Alveolar and Interstitial Lung Macrophages in Rhesus Macaques: Implications for Understanding Lung Disease in Humans , 2014, The Journal of Immunology.

[97]  M. Anstead,et al.  Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[98]  Tom C. Freeman,et al.  Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation , 2014, Immunity.

[99]  H. Hoogsteden,et al.  Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis. , 2013, Pulmonary pharmacology & therapeutics.

[100]  Wen-jie Ji,et al.  Spironolactone Attenuates Bleomycin-Induced Pulmonary Injury Partially via Modulating Mononuclear Phagocyte Phenotype Switching in Circulating and Alveolar Compartments , 2013, PloS one.

[101]  H. Perlman,et al.  Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. , 2013, American journal of respiratory cell and molecular biology.

[102]  A. Ryan,et al.  Accelerated Development of Pulmonary Fibrosis via Cu,Zn-superoxide Dismutase-induced Alternative Activation of Macrophages* , 2013, The Journal of Biological Chemistry.

[103]  S. Gordon,et al.  Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. , 2013, Blood.

[104]  Wei Zhang,et al.  Expression of pulmonary aquaporin 1 is dramatically upregulated in mice with pulmonary fibrosis induced by bleomycin , 2012, Archives of medical science : AMS.

[105]  R. Homer,et al.  Chronic inflammation and lung fibrosis: pleotropic syndromes but limited distinct phenotypes , 2012, Mucosal Immunology.

[106]  T. Wynn,et al.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.

[107]  G. Natoli,et al.  Transcriptional regulation of macrophage polarization: enabling diversity with identity , 2011, Nature Reviews Immunology.

[108]  S. Forbes,et al.  Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. , 2011, American journal of respiratory and critical care medicine.

[109]  H. Erdjument-Bromage,et al.  TLR signaling augments macrophage bactericidal activity through mitochondrial ROS , 2011, Nature.

[110]  H. Lockstone,et al.  IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses , 2011, Nature Immunology.

[111]  Michael S. Kramer,et al.  TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P. , 2011, The international journal of biochemistry & cell biology.

[112]  Baohui Xu,et al.  Effect of an immunotoxin to folate receptor β on bleomycin‐induced experimental pulmonary fibrosis , 2010, Clinical and experimental immunology.

[113]  L. de Leval,et al.  Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. , 2009, The Journal of clinical investigation.

[114]  L. Jermutus,et al.  Identification of cyclic peptides able to mimic the functional epitope of IgG1-Fc for human FcγRI , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[115]  Xia Zhang,et al.  The Isolation and Characterization of Murine Macrophages , 2008, Current protocols in immunology.

[116]  R. Chambers,et al.  Escape from the matrix: multiple mechanisms for fibroblast activation in pulmonary fibrosis. , 2008, Proceedings of the American Thoracic Society.

[117]  M. Anstead,et al.  Azithromycin alters macrophage phenotype. , 2008, The Journal of antimicrobial chemotherapy.

[118]  C. Marsh,et al.  The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. , 2008, Antioxidants & redox signaling.

[119]  T. Wynn,et al.  Cellular and molecular mechanisms of fibrosis , 2008, The Journal of pathology.

[120]  Philip S Low,et al.  Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. , 2008, Accounts of chemical research.

[121]  H. Gascan,et al.  Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. , 2007, Blood.

[122]  A. Prasse,et al.  CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. , 2007, Arthritis and rheumatism.

[123]  Shuming Nie,et al.  Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging. , 2006, Nanomedicine.

[124]  Antje Prasse,et al.  A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. , 2006, American journal of respiratory and critical care medicine.

[125]  J. Ravetch,et al.  Fcgamma receptors: old friends and new family members. , 2006, Immunity.

[126]  A. Ho,et al.  Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. , 2005, Blood.

[127]  B. Dahal,et al.  Macrophage galactose‐type C‐type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation , 2005, Journal of leukocyte biology.

[128]  A. Mantovani,et al.  Transcriptional Profiling Reveals Complex Regulation of the Monocyte IL-1β System by IL-131 , 2005, The Journal of Immunology.

[129]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[130]  T. Fujita,et al.  TIR-containing Adapter Molecule (TICAM)-2, a Bridging Adapter Recruiting to Toll-like Receptor 4 TICAM-1 That Induces Interferon-β* , 2003, Journal of Biological Chemistry.

[131]  C. Sköld,et al.  Functional and morphological differences between human alveolar and interstitial macrophages. , 2001, Experimental and molecular pathology.

[132]  R. Boucher,et al.  Expression and localization of epithelial aquaporins in the adult human lung. , 2001, American journal of respiratory cell and molecular biology.

[133]  D. Levy,et al.  Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease , 1996, Cell.

[134]  Shigeru Tsuchiya,et al.  Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1) , 1980, International journal of cancer.

[135]  JoVE Video Dataset , 2022 .